Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells.

Papi, M

Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. [electronic resource] - Nanoscale Jul 2017 - 10327-10334 p. digital

Publication Type: Journal Article

2040-3372

10.1039/c7nr03042h doi


Antineoplastic Agents--administration & dosage
Cell Line, Tumor
Drug Delivery Systems
Humans
Liposomes
Nanoparticles--chemistry
Polyethylene Glycols--chemistry
Protein Corona